Business Context and Reporting Period
Company: CorMedix Inc. (CRMD)
Filing Type: Form 8-K (Current Report)
Report Date: August 13, 2026
Reporting Period: Quarter ended June 30, 2026
Context: The filing serves to announce the Company's financial results for the second quarter of 2026 via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text acts as a cover document referencing a press release (Exhibit 99.1) but does not contain specific financial data tables or figures within the body of this text.
- Revenue: Not provided in the filing text.
- Profit/Loss: Not provided in the filing text.
- Cash Flow: Not provided in the filing text.
- Margins: Not provided in the filing text.
- Debt and Liquidity: Not provided in the filing text.
Material Changes
The filing text does not provide specific numerical comparisons or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q2 2026 results but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 13, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the press release.
- Check for updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the status of the Company's liquidity and capital resources as detailed in the full financial report.